1992PubMedRequires access

Dapsone induced motor polyneuropathy.

A. J. W. Jacob, A. Rajendran, João Pedro De Carvalho Menezes, M. Vaz

Open publisher page 1 citations

Abstract

Dapsone induced neuropathy has been docu­ mented during the management of a variety of skin disorders requiring a high dose ot dapsone. In leprosy however, the diagnosis is complicated by the occurrence of nerve deficits as a part of the disease process. While dapsone-induced neuro­ pathy is clearly not the major cause for neurologi­ cal damage in leprosy, the importance of diagnos­ ing it is underscored by the often dramatic re­ covery of nerve function which occurs after stopp­ ing the drug. It is likely that this side-effect is under-diagnosed in leprosy patients and is mis­ taken for a neural deficit related to reactional states. The present paper reports the occurrence of dapsone-induced neuropathy during the treat­ ment regimen for leprosy, and outlines certain criteria which Will aid in its diagnosis.

About this research paper

What this paper is about

Dapsone induced neuropathy has been docu­ mented during the management of a variety of skin disorders requiring a high dose ot dapsone. In leprosy however, the diagnosis is complicated by the occurrence of nerve deficits as a part of the disease process. While dapsone-induced neuro­ pathy is clearly not the major cause for neurologi­ cal damage in leprosy, the importance of diagnos­ ing it is underscored by the often dramatic re­ covery of nerve function which occurs after stopp­ ing the drug. It is likely that this side-effect is under-diagnosed in leprosy patients and is mis­ taken for a neural deficit related to reactional states. The present paper reports the occurrence of dapsone-induced neuropathy during the treat­ ment regimen for leprosy, and outlines certain criteria which Will aid in its diagnosis.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Dapsone induced neuropathy has been docu­ mented during the management of a variety of skin disorders requiring a high dose ot dapsone. In leprosy however, the diagnosis is complicated by the occurrence of nerve deficits as a part of the disease process. While dapsone-induced neuro­ pathy is clearly not the major cause for neurologi­ cal damage in leprosy, the importance of diagnos­ ing it is underscored by the often dramatic re­ covery of nerve function which occurs after stopp­ ing the drug. It is likely that this side-effect is under-diagnosed in leprosy patients and is mis­ taken for a neural deficit related to reactional states. The present paper reports the occurrence of dapsone-induced neuropathy during the treat­ ment regimen for leprosy, and outlines certain criteria which Will aid in its diagnosis.

Key concepts: Dapsone, Leprosy, Polyneuropathy, Medicine, Dermatology, Surgery, Pediatrics

Related papers

Back to paper searchBrowse research topicsOriginal source
Dapsone induced motor polyneuropathy. — Research Paper | ScholarLens